Related Experiment Video
Updated: May 25, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
Claudin-4 as therapeutic target in cancer
A Neesse1, H Griesmann, T M Gress
1Department of Gastroenterology, Endocrinology and Metabolism, Philipps University Marburg, Baldinger Str., 35043 Marburg, Germany.
Background:
Intercellular junctional complexes such as adherens junctions and tight junctions are critical regulators of cellular polarity, paracellular permeability and metabolic and structural integrity of cellular networks. Abundant expression analysis data have yielded insights into the complex pattern of differentially expressed cell-adhesion proteins in epithelial cancers and provide a useful platform for functional, preclinical and clinical evaluation of novel targets.
Scope Of Review:
This review will focus on the role of claudin-4, an integral constituent of tight junctions, in the pathophysiology of epithelial malignancies with particular focus pancreatic cancer, and its potential applicability for prognostic, diagnostic and therapeutic approaches.
Major Conclusions:
Claudin-4 expression is widely dysregulated in epithelial malignancies and in a number of premalignant precursor lesions. Although the functional implications are only starting to unravel, claudin-4 seems to play an important role in tumour cell invasion and metastasis, and its dual role as receptor of Clostridium perfringens enterotoxin (CPE) opens exciting avenues for molecular targeted approaches.
General Significance:
Claudin-4 constitutes a promising molecular marker for prognosis, diagnosis and therapy of epithelial malignancies.
Insights
Claudin-4, a tight junction protein, is frequently altered in epithelial cancers. Its role in tumor invasion and as a receptor for Clostridium perfringens enterotoxin (CPE) offers new diagnostic and therapeutic strategies.
Area of Science:
- Cell biology
- Oncology
- Molecular medicine
Background:
- Intercellular junctions, including adherens and tight junctions, are crucial for cellular polarity, permeability, and tissue integrity.
- Expression analysis of cell-adhesion proteins in epithelial cancers reveals complex patterns, offering targets for evaluation.
- Tight junctions, composed of proteins like claudins, play vital roles in maintaining epithelial barrier function.
Purpose of the Study:
- To review the role of claudin-4 in the pathophysiology of epithelial malignancies.
- To explore the potential of claudin-4 in prognostic, diagnostic, and therapeutic applications, with a focus on pancreatic cancer.
Main Methods:
- Literature review focusing on claudin-4.
- Analysis of expression data in epithelial cancers.
- Examination of claudin-4's role as a receptor for Clostridium perfringens enterotoxin (CPE).
Main Results:
- Claudin-4 expression is dysregulated in various epithelial malignancies and premalignant lesions.
- Claudin-4 appears to significantly influence tumor cell invasion and metastasis.
- Claudin-4 serves as a receptor for CPE, suggesting targeted therapeutic potential.
Conclusions:
- Claudin-4 is a promising molecular marker for the prognosis, diagnosis, and therapy of epithelial cancers.
- The dysregulation of claudin-4 in cancer highlights its importance in disease progression.
- Targeting claudin-4, potentially via its interaction with CPE, presents novel therapeutic avenues.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Tight Junctions
Abnormal Proliferation

